reported in a propensity score-matched population-based cohort analysis that GLP-1 receptor agonist use in patients with MASLD and type 2 diabetes was associated with a lower risk of HCC (aHR: 0.55, 95%CI: 0.44-0.69) and all-cause mortality (aHR: 0.62, 95%CI: 0.55-0.71) [59]
No peer-reviewed human trials examining the specific efficacy of over-the-counter botanical supplement patches for GLP-1 pathway support have been published as of this review
Oleate increase neutral lipid accumulation, cellular respiration and rescues palmitate-exposed GLP-1 secreting cells by reducing ceramide-induced ROS
Recently, a single-blind clinical trial of exendin-4 in PD patients showed that exenatide was well tolerated, and the treated group exhibited clinically relevant improvements across motor and cognitive measures compared with the control group (Aviles-Olmos et al., 2013)
Another concern for athletes: One clinical trial of Ozempic showed that it increases heart rate one to six beats per minute, but endurance athletes are typically striving to keep their heart ratesmarkers of fitness and recovery abilitylow
-1.jpg)
